Kristi Jones

Amministratore Delegato presso NEXIMMUNE, INC.

Patrimonio netto: 8 067 $ in data 30/06/2024

60 anni

Health Technology

Consumer Services

Posizioni attive di Kristi Jones

Società	Posizione	Inizio	Fine
NEXIMMUNE, INC.	Direttore/Membro del Consiglio	15/02/2022	-
	Amministratore Delegato	15/02/2022	-
	Presidente	15/02/2022	-
	Direttore operativo	01/03/2018	15/02/2022
	Corporate Officer/Principal	01/06/2017	01/03/2018

Società	Posizione	Inizio	Fine
AstraZeneca, Inc. AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines.	Corporate Officer/Principal	01/01/2013	01/01/2015
MedImmune LLC MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.	Corporate Officer/Principal	01/11/2011	01/07/2013
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	-	-

Ut College of Pharmacy	Undergraduate Degree
Texas Tech University	Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	4
Undergraduate Degree	2
Director/Board Member	1

Settori

Health Technology	5
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
NEXIMMUNE, INC.	Health Technology

Aziende private	3
AstraZeneca, Inc. AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines.	Health Technology
MedImmune LLC MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.	Health Technology
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Health Technology